RE: Hi guys24 Apr 2020 20:43
Yes correct Stanley. This is why primerdesign has its new dPCR being launched. What’s your thoughts on this. The 8m manufacturing capacity planned and already been increased? Sales to over 80 countries, a distribution network. Order book absolutely full. That’s real sales real revenue. Approved basically worldwide, who, fda etc. Did nearly 15m revenue last year with other products and expecting 17m this year with these other products. And novacyt is only a 250m cap.
Now avcta. No test right now, no guarantee the test will work, not proved a damn thing apart from a good story to get placing away, not a given on accuracy of test, not a given there will be a market 100%, no approvals, no useage, no revenue, no sales, no order book, no manufacturing, no supply chain and a shared “potential” product with multiples. Now even if you get an accurate product (no guarantee again as I still think you are a few weeks away from this) then few more weeks for approvals etc. So let’s say 2 months from now at best. I think avcta did around 2m in revenue last year? it is already £163m mcap! I would say overvalued and more than priced in. What if you don’t actually get an accurate product, any approvals, any sales. Caaaarnage no? ( a little like aim minor oil players that talk about a great find, the best find ever but is it even there or commercially viable, I think you’ll easily relate to that ;) ) Are you late to the party actually very late as you haven’t even been born yet! Is every dirty trader in twitter pumping? Yep.
So if you see a see more value in avcta at current share price then you must see a hell of a lot in novacyt if you don’t then quite simply you’re mugging yourself off and deramping avcta. Now do you want me to come and troll avcta or shall we just concentrate on our investments and hope that all testing works, helps us get out log lockdown and we find a cure for a vaccine. I also would not be surprised in the slightest that you will take a position here next week.
Well done on catching some of avcta rise though. Enjoy that board b
Sign In
Follow the stocks
